Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imiquimod Induces Complete Clearance of a PUVA-Resistant Plaque in Mycosis fungoides
Reinhard Dummer, Mirjana Urosevic, Werner Kempf, et al.
Dermatology (2003) Vol. 207, Iss. 1, pp. 116-118
Closed Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Management of Refractory Early-Stage Cutaneous T-Cell Lymphoma
Margit A. Huber, G. Staib, Hubert Pehamberger, et al.
American Journal of Clinical Dermatology (2006) Vol. 7, Iss. 3, pp. 155-169
Closed Access | Times Cited: 24
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
Paula Di Sciullo, Florencia Menay, Federico Cocozza, et al.
Clinical Immunology (2019) Vol. 203, pp. 154-161
Open Access | Times Cited: 15
Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod
Matthew C. Gordon, Jason C. Sluzevich, Anokhi Jambusaria‐Pahlajani
JAAD Case Reports (2015) Vol. 1, Iss. 6, pp. 348-350
Open Access | Times Cited: 14
Future Perspectives in the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Reinhard Dummer
Seminars in Oncology (2006) Vol. 33, pp. 33-36
Closed Access | Times Cited: 21
Mycosis fungoides: Current trends in diagnosis and management
Saumya Panda
Indian Journal of Dermatology (2007) Vol. 52, Iss. 1, pp. 5-5
Open Access | Times Cited: 19
Therapeutic advances in cutaneous T-cell lymphoma.
Oleg E. Akilov, Larisa J. Geskin
PubMed (2011)
Closed Access | Times Cited: 14
Skin-Directed Therapies in Cutaneous T-Cell Lymphoma
Cuong V. Nguyen, Kimberly Bohjanen
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 683-696
Open Access | Times Cited: 13
Standard and experimental therapy in cutaneous T‐cell lymphomas
Reinhard Dummer, Antonio Cozzio, Sibylle Meier, et al.
Journal of Cutaneous Pathology (2006) Vol. 33, Iss. s1, pp. 52-57
Closed Access | Times Cited: 18
Innovative Therapy of Cutaneous T-Cell Lymphoma: Beyond Psoralen and Ultraviolet Light and Nitrogen Mustard
Brian Poligone, Peter Heald
Dermatologic Clinics (2010) Vol. 28, Iss. 3, pp. 501-510
Open Access | Times Cited: 11
Cutaneous Lymphomas: Molecular Pathways Leading to New Drugs
Reinhard Dummer, Simone M. Goldinger, Antonio Cozzio, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 3, pp. 517-525
Open Access | Times Cited: 11
Emerging treatment options for early mycosis fungoides
Montse Fernández‐Guarino
Clinical Cosmetic and Investigational Dermatology (2013), pp. 61-61
Open Access | Times Cited: 10
Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature
Doaa Shalabi, Nish Vadalia, Neda Nikbakht
Dermatology and Therapy (2019) Vol. 9, Iss. 4, pp. 807-814
Open Access | Times Cited: 10
Emerging drugs in cutaneous T-cell lymphomas
Reinhard Dummer
Expert Opinion on Emerging Drugs (2005) Vol. 10, Iss. 2, pp. 381-392
Closed Access | Times Cited: 12
Cutaneous T-Cell Lymphoma
Ellen J. Kim, Camille E. Introcaso, Stephen K. Richardson, et al.
Springer eBooks (2008), pp. 411-437
Closed Access | Times Cited: 7
Cutaneous T-Cell Lymphoma: The Yin and Yang of Inflammation and Neoplasia
Xuesong Wu, Sam T. Hwang
Journal of Investigative Dermatology Symposium Proceedings (2015) Vol. 17, Iss. 1, pp. 34-35
Open Access | Times Cited: 5
Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod
Michael Lindberg
Cutis (2023) Vol. 111, Iss. 1
Open Access | Times Cited: 2
Combination of Bexarotene and Psoralen-UVA Therapy in a Patient with Mycosis fungoides
Sonja Michaelis, Antonio Cozzio, Werner Kempf, et al.
Dermatology (2004) Vol. 209, Iss. 1, pp. 72-74
Closed Access | Times Cited: 8
Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion
Angela Landrigan, Gloria Yiu, K. K. Agarwal, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2011) Vol. 53, Iss. 1, pp. 166-168
Open Access | Times Cited: 3
Mycosis Fungoides
Lorenzo Cerroni, DPhil Kevin Gatter BM, Helmut Kerl
(2009), pp. 11-56
Closed Access | Times Cited: 3
Immunomodulation Within a Single Tumor Site to Induce Systemic Antitumor Immunity: In Situ Vaccination for Cancer
Linda Hammerich, Joshua Brody
Springer eBooks (2016), pp. 129-162
Closed Access | Times Cited: 2
Irradiation therapy: from UV light to electron beam
Renato G. Panizzon
Journal of Cutaneous Pathology (2006) Vol. 33, Iss. s1, pp. 43-46
Closed Access | Times Cited: 4
Harnessing the immune system in the treatment of cutaneous T cell lymphomas
Christopher J. Fay, Katherine C. Awh, Nicole R. LeBoeuf, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
Cutaneous T-Cell Lymphoma
Sasha Stephen, Ellen J. Kim, Camille E. Introcaso, et al.
Springer eBooks (2017), pp. 715-740
Closed Access | Times Cited: 2
Mycosis Fungoides
Lorenzo Cerroni, DPhil Kevin Gatter BM, Helmut Kerl
(2004), pp. 9-38
Closed Access | Times Cited: 3
Standard- und experimentelle Therapie kutaner T-Zell-Lymphome
Michael Beyeler, Reinhard Dummer
Der Hautarzt (2003) Vol. 54, Iss. 12, pp. 1177-1184
Closed Access | Times Cited: 3

Scroll to top